Literature DB >> 25865191

Is there interaction between gut microbial profile and cardiovascular risk in chronic kidney disease patients?

Amanda F Barros1, Natália A Borges, Dennis C Ferreira, Flávia L Carmo, Alexandre S Rosado, Denis Fouque, Denise Mafra.   

Abstract

AIM: To evaluate the gut microbial profile in chronic kidney disease (CKD) patients and evaluate the possible relationship with inflammation and cardiovascular risk. PATIENTS &
METHODS: Markers inflammation plasma and bacterial community profile (denaturing gradient gel electrophoresis) were analyzed.
RESULTS: The average number of bands was not different in healthy individuals and CKD patients. The number of bands was negatively associated with plasma levels of VCAM-1 in patients. Flavobacteriaceae bacterium and Listeria monocytogenes were found in patients and Lachnospiraceae bacterium and Butyrivibrio crossotus in healthy individuals.
CONCLUSION: Although CKD patients did not present altered gut microbial profile, the sequencing of bands suggested a different microbiota between groups. The result suggests a possible relationship between gut microbiota and cardiovascular risk in CKD patients.

Entities:  

Keywords:  cardiovascular diseases; chronic renal failure; gut microbiota; inflammation; oxidative stress

Mesh:

Year:  2015        PMID: 25865191     DOI: 10.2217/fmb.14.140

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  15 in total

Review 1.  Resistant starch for modulation of gut microbiota: Promising adjuvant therapy for chronic kidney disease patients?

Authors:  Cristiane Moraes; Natália A Borges; Denise Mafra
Journal:  Eur J Nutr       Date:  2016-01-30       Impact factor: 5.614

Review 2.  The Effects of High-Protein Diets on Kidney Health and Longevity.

Authors:  Gang-Jee Ko; Connie M Rhee; Kamyar Kalantar-Zadeh; Shivam Joshi
Journal:  J Am Soc Nephrol       Date:  2020-07-15       Impact factor: 10.121

3.  Can curcumin supplementation reduce plasma levels of gut-derived uremic toxins in hemodialysis patients? A pilot randomized, double-blind, controlled study.

Authors:  Roberta T Salarolli; Livia Alvarenga; Ludmila F M F Cardozo; Karla T R Teixeira; Laís de S G Moreira; Jordana D Lima; Silvia D Rodrigues; Lia S Nakao; Denis Fouque; Denise Mafra
Journal:  Int Urol Nephrol       Date:  2021-01-12       Impact factor: 2.370

4.  Gastrointestinal Microbiota in Patients with Chronic Kidney Disease: A Systematic Review.

Authors:  SeonYoon Chung; Jennifer L Barnes; Kim Schafer Astroth
Journal:  Adv Nutr       Date:  2019-09-01       Impact factor: 8.701

Review 5.  Microbiota in health and diseases.

Authors:  Kaijian Hou; Zhuo-Xun Wu; Xuan-Yu Chen; Jing-Quan Wang; Dongya Zhang; Chuanxing Xiao; Dan Zhu; Jagadish B Koya; Liuya Wei; Jilin Li; Zhe-Sheng Chen
Journal:  Signal Transduct Target Ther       Date:  2022-04-23

Review 6.  The gut microbiome, diet, and links to cardiometabolic and chronic disorders.

Authors:  Judith Aron-Wisnewsky; Karine Clément
Journal:  Nat Rev Nephrol       Date:  2015-11-30       Impact factor: 28.314

7.  Effect of Synbiotic and Probiotic Supplementation on Serum Levels of Endothelial Cell Adhesion Molecules in Hemodialysis Patients: a Randomized Control Study.

Authors:  Neda Haghighat; Majid Mohammadshahi; Shokouh Shayanpour; Mohammad Hossein Haghighizadeh
Journal:  Probiotics Antimicrob Proteins       Date:  2019-12       Impact factor: 4.609

8.  Gut microbiota and inflammation in chronic kidney disease patients.

Authors:  Denise Mafra; Denis Fouque
Journal:  Clin Kidney J       Date:  2015-05-06

Review 9.  The molecular mechanisms of hemodialysis vascular access failure.

Authors:  Akshaar Brahmbhatt; Andrea Remuzzi; Marco Franzoni; Sanjay Misra
Journal:  Kidney Int       Date:  2016-02       Impact factor: 10.612

10.  Western Indian Rural Gut Microbial Diversity in Extreme Prakriti Endo-Phenotypes Reveals Signature Microbes.

Authors:  Nar S Chauhan; Rajesh Pandey; Anupam K Mondal; Shashank Gupta; Manoj K Verma; Sweta Jain; Vasim Ahmed; Rutuja Patil; Dhiraj Agarwal; Bhushan Girase; Ankita Shrivastava; Fauzul Mobeen; Vikas Sharma; Tulika P Srivastava; Sanjay K Juvekar; Bhavana Prasher; Mitali Mukerji; Debasis Dash
Journal:  Front Microbiol       Date:  2018-02-13       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.